1alpha,25-Dihydroxyvitamin D(3) to skew intratumoral levels of immune inhibitory CD34(+) progenitor cells into dendritic cells.
about
Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trialsHampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancerImproving cancer immunotherapy by targeting the STATe of MDSCsPrognostic significance of vitamin D receptor polymorphisms in head and neck squamous cell carcinoma.Immunotherapy for head and neck cancer: advances and deficiencies.Serum vitamin D levels of patients with oral squamous cell carcinoma (OSCC) and expression of vitamin D receptor in oral precancerous lesions and OSCC.Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma.Immunological modulation by 1α,25-dihydroxyvitamin D3 in patients with squamous cell carcinoma of the head and neck.Cytokine and Adipokine Levels in Patients with Premalignant Oral Lesions or in Patients with Oral Cancer Who Did or Did Not Receive 1α,25-Dihydroxyvitamin D3 Treatment upon Cancer Diagnosis.Immune regulatory activity of vitamin d3 in head and neck cancerPotential therapeutic anti-tumor effect of a Salmonella-based vaccine.Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets.Is 1,25-dihydroxyvitamin D3 receptor expression a potential Achilles' heel of CD44+ oral squamous cell carcinoma cells?Targeting Myeloid-Derived Suppressor Cells in Cancer.Influence of vitamin D on cancer risk and treatment: Why the variability?
P2860
Q21089763-09967EBF-C05D-417E-A62C-BF0A6BE4725BQ26863418-CAB91484-EF98-4A03-ACE6-736A12556572Q28066797-6A214D1F-415F-4A11-A4CE-BA4596F130D3Q34126506-AD90107C-FA9E-4D72-AECC-3D975780AB3AQ35072040-82F4AC92-49DC-4425-AD1B-A1B171B898A8Q35374106-C89D1F30-474C-473E-AADE-56FE18D32324Q35915614-F0C33FB5-48C0-4AB7-8D62-95CB672A7DC5Q35922983-39B4BA2A-F98A-4B87-A4CB-27389417A887Q36102797-FD3FAE33-69B1-4E7B-839B-81E22845C939Q37226517-F6656071-565B-49C0-9F76-EC9F4D202CC9Q37530067-654F4746-8376-48B6-B67E-9E46C2DF0131Q38269370-B3D25076-1DF9-43C4-9033-ED55AA63A4AFQ45332975-D74036B1-ED8B-42E0-8587-699A185B41B0Q47765346-ADCA11DB-0DFD-4A81-8EF6-507A95113AACQ58133485-85A69036-D4CC-4A3A-9912-E9EA054B89AB
P2860
1alpha,25-Dihydroxyvitamin D(3) to skew intratumoral levels of immune inhibitory CD34(+) progenitor cells into dendritic cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
1alpha,25-Dihydroxyvitamin D(3 ...... or cells into dendritic cells.
@ast
1alpha,25-Dihydroxyvitamin D(3 ...... or cells into dendritic cells.
@en
type
label
1alpha,25-Dihydroxyvitamin D(3 ...... or cells into dendritic cells.
@ast
1alpha,25-Dihydroxyvitamin D(3 ...... or cells into dendritic cells.
@en
prefLabel
1alpha,25-Dihydroxyvitamin D(3 ...... or cells into dendritic cells.
@ast
1alpha,25-Dihydroxyvitamin D(3 ...... or cells into dendritic cells.
@en
P2093
P2860
P1476
1alpha,25-Dihydroxyvitamin D(3 ...... or cells into dendritic cells.
@en
P2093
Jonathan S Kulbersh
M Boyd Gillespie
M Rita I Young
Terry A Day
P2860
P304
P356
10.1016/J.OTOHNS.2008.11.011
P577
2009-02-01T00:00:00Z